Hansoh Pharma announces ARTEMIS-008 phase 3 trial of risvutatug rezetecan meets primary endpoint of overall survival in small cell lung cancer: Shanghai Monday, July 13, 2026, 18: ...
Emcure Pharmaceuticals Limited announced the consolidation of its shareholding in biopharma subsidiary Gennova Biopharmaceuticals Limited, alongside a leadership transition, as it sharpens its focus ...
CureMeAbroad aims to facilitate $100 million in treatments by 2027: Our Bureau, Mumbai Monday, July 13, 2026, 17:20 Hrs [IST] CureMeAbroad, the global medical tourism discovery an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results